Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Every new patient completes a detailed health assessment that is reviewed by licensed healthcare providers, allowing recommendations to be based on medical history, current health status, and individual goals instead of a standardized process
Clinical Trial Data The landmark STEP-1 trial studied Wegovy (semaglutide 2.4 mg) in 1,961 adults over 68 weeks
It describes stability testing that evaluates how the compound performs under defined storage conditions and identifies the point at which potency falls below acceptable therapeutic levels
The added glucagon receptor component is the variable, but nothing in the 48-week data suggests it introduces problems over time
US$ 20.08
US$ 29.52
US$ 25.52
